Prior to investigate the direct impact of Rb1 on NETs-induced endothelial activation, we evaluated the pharmacological effects of Rb1 treatment on atherosclerosis-associated endothelial activation in the HFD-fed Apoe−/− mice in vivo. The gene discussed is RB1; the disease is atherosclerosis.